Intra‐articular injections in people with haemophilia in the COVID‐19 era

Corte‐Rodríguez, Hortensia De la; Rodríguez-Merchán, E. Carlos; Álvarez‐Román, María Teresa; Jiménez‐Yuste, Víctor

doi:10.1111/hae.14070

Cited by 4 publications

(4 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The impact of SARS-CoV-2 virus infection on patients with CBD is unknown, therefore it is assumed that this group of patients is not protected against thromboembolic or cardiovascular complications. For this reason, patients with a CBD should receive similar anticoagulation therapy to patients without coagulopathy [ 65 , 66 ].…”

Section: Resultsmentioning

confidence: 99%

“…In each case, the decision on the procedure and possible hospitalization should be made on an individual basis, after assessment of the potential risks and benefits. It is recommended to limit contact with the patient, therefore medical records and telemedical consultation are important [ 66 ]. The literature describes the case of a 56-year-old man with a severe form of hemophilia A, who underwent orthopedic surgery despite the difficult epidemic situation.…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Practical Recommendations for Treatment of Dental Patients with Congenital Bleeding Disorders during the Covid-19 Pandemic: A Narrative Review

Czajkowska

Rupa‐Matysek

Gil

et al. 2020

IJERPH

View full text Add to dashboard Cite

At the end of 2019, a new disease—COVID-19—was identified, and a few months later, the World Health Organization announced a pandemic. It is now known that SARS-CoV-2 is highly contagious and most confirmed infections are mild to moderate. The situation is particularly difficult for dentists due to the high risk of virus transmission in the dental surgery. Complications including, but not limited to, problems with the respiratory and cardiovascular systems have been reported in patients with SARS-CoV-2. Several changes in the coagulation system, such as lower platelet numbers or increased prothrombin time, as well as increased D-dimer and fibrinogen, were observed. This review is intended to systematize the knowledge on the treatment of patients with congenital bleeding disorders (CBD) during the SARS-CoV-2 pandemic. Extensive literature research was conducted into COVID-19 and the general medical and dental treatment of patients with CBD. Case studies, research results and recommendations of international societies were used in the study. The results of this research are presented in the form of recommendations for the treatment of patients with coagulopathies. It should be remembered that the impact of COVID-19 on the health condition of patients with CBD is unknown to date.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Practical Recommendations for Treatment of Dental Patients with Congenital Bleeding Disorders during the Covid-19 Pandemic: A Narrative Review

Czajkowska

Rupa‐Matysek

Gil

et al. 2020

IJERPH

View full text Add to dashboard Cite

show abstract

“…Um lange Wartezeiten und damit verbundene negative Folgen (z. B. Zunahme von Schmerzen, Blutungen, Bewegungseinschränkungen) zu vermeiden, könnten notwendige elektive Eingriffe unter Einhaltung entsprechender Hygienemaßnahmen durchgeführt werden 32 . Allgemein gelten für Patienten mit IBD dieselben präventiven hygienischen Maßnahmen wie für die Allgemeinbevölkerung 33 .…”

Section: Diskussionunclassified

Auswirkungen der COVID-19 Pandemie auf die medizinische Versorgung von Patienten mit angeborenen Blutungsneigungen

Olivieri

Halimeh

Wermes³

et al. 2021

Gesundheitswesen

View full text Add to dashboard Cite

Zusammenfassung Fragestellung Chronische Erkrankungen, wie z. B. angeborene Blutungsneigungen (IBD: Inherited Bleeding Disorders), gehen häufig mit einem erhöhten Versorgungsaufwand einher. Maßnahmen zur Eindämmung der COVID-19 Pandemie, inklusive Isolation und Triageierung, haben zu Einschränkungen in der Krankenversorgung von chronisch kranken Patienten geführt. Ziel der vorliegenden Arbeit ist es, die Auswirkungen der COVID-19 Pandemie auf die Krankenversorgung von IBD-Patienten zu untersuchen. Methodik In dieser multizentrischen Querschnittsstudie zur Bewertung der Auswirkungen von COVID-19 auf die psychische Gesundheit und Versorgungsqualität von Patienten mit angeborener Blutungsneigung wurde ein ad-hoc Fragebogen an 586 Patienten/Eltern von Kindern mit Hämophilie A, B oder von Willebrand Syndrom Typ 3 verschickt. Neben demografischen und klinischen Daten wurden IBD Patienten zu ihren Gedanken, Sorgen und Erfahrungen in Bezug auf ihre medizinische Versorgung während der COVID-19 Pandemie befragt. Unterschiede zwischen klinischen Subgruppen wurden berechnet. Ergebnisse Signifikante Unterschiede zeigten sich zwischen Subgruppen (Schweregrad, Art der Therapie, Produktklasse, Komorbiditäten) bezüglich Übertragung von COVID-19 durch Plasmaprodukte, Auswirkungen COVID-19 positiver Testergebnisse, Angst COVID-19 zu bekommen, verzögerter Medikamentenversorgung und Physiotherapiebehandlung. Diskussion Die medizinische Versorgung von IBD-Patienten, die eine kontinuierliche Versorgung mit lebensnotwendigen Medikamenten benötigen, stellt in Pandemiezeiten eine besondere Herausforderung dar. Daher sollten Sorgen und Ängste von IBD-Patienten ernst genommen und innovative Kommunikationswege zur Aufrechterhaltung von Therapiestandards und Versorgungsqualität etabliert werden.

show abstract

“…Consideration should be given to dispensing with the use of corticosteroids and nonsteroidal anti-inflammatory drugs whenever possible. The need for interventional techniques should be carefully assessed and postponed if possible [42,43]. Ultimately, the aspect of pain should always be included in comprehensive care for patients with hemophilia, the COVID-19 era being no exception.…”

Section: Pain Management Considerationsmentioning

confidence: 99%

What COVID-19 can mean for people with hemophilia beyond the infection risk

Corte‐Rodríguez¹,

Álvarez‐Román²,

Rodríguez-Merchán³

et al. 2020

Expert Review of Hematology

View full text Add to dashboard Cite

Introduction: The coronavirus disease 2019 (COVID-19) pandemic represents an unprecedented global health crisis. To combat its effects, many governments have opted for strategies of social isolation that involve a radical change in people's behavior. Areas covered: For patients with hemophilia, the negative consequences of these measures can be greater, given they modify aspects of health care and lifestyles needed to counteract the adverse effects of hemophilia. The long-term consequences of the pandemic on patients with hemophilia are not well known. The aim of this special report is to show what COVID-19 could mean for this population, beyond the risk of infection. Expert opinion: Considerations of the clinical, care, therapeutic, physical, nutritional, mental health, pain, and disability aspects that might be affected are included. Strategies are also suggested to minimize the effects that these issues can have on patients' lives. Patients, health professionals, and society as a whole must work together to mitigate the effects of the pandemic on people with hemophilia.

show abstract

Intra‐articular injections in people with haemophilia in the COVID‐19 era

Cited by 4 publications

References 8 publications

Practical Recommendations for Treatment of Dental Patients with Congenital Bleeding Disorders during the Covid-19 Pandemic: A Narrative Review

Practical Recommendations for Treatment of Dental Patients with Congenital Bleeding Disorders during the Covid-19 Pandemic: A Narrative Review

Auswirkungen der COVID-19 Pandemie auf die medizinische Versorgung von Patienten mit angeborenen Blutungsneigungen

What COVID-19 can mean for people with hemophilia beyond the infection risk

Contact Info

Product

Resources

About